{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+Propionate%2FSalmeterol+Combination+Product&page=2", "query": { "intervention": "Fluticasone Propionate/Salmeterol Combination Product", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 46, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+Propionate%2FSalmeterol+Combination+Product&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+Propionate%2FSalmeterol+Combination+Product&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T08:19:12.521Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00920959", "title": "Advair Pediatric Once-Daily", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 908, "start_date": "2001-11", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2016-09-15", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 141, "location_summary": "Ozark, Alabama • Tucson, Arizona • Little Rock, Arkansas + 118 more", "locations": [ { "city": "Ozark", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00920959" }, { "nct_id": "NCT00400608", "title": "A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "ADVAIR HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 28, "start_date": "2006-10", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 3, "location_summary": "Huntington Beach, California • Long Beach, California • Medford, Oregon", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400608" }, { "nct_id": "NCT01817764", "title": "A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Umeclidinium/vilanterol", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 707, "start_date": "2013-03-01", "completion_date": "2013-10-25", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 9, "location_summary": "Jasper, Alabama • Phoenix, Arizona • San Diego, California + 6 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01817764" }, { "nct_id": "NCT01772368", "title": "Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "FS MDPI", "type": "DRUG" }, { "name": "Advair Diskus", "type": "DRUG" }, { "name": "Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 72, "start_date": "2013-01", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2017-06-12", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 10, "location_summary": "Denver, Colorado • North Dartmouth, Massachusetts • St Louis, Missouri + 7 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Skillman", "state": "New Jersey" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01772368" }, { "nct_id": "NCT02024204", "title": "Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Diseases", "Medication Compliance" ], "interventions": [ { "name": "Fluticasone propionate 230mcg for 3 Months", "type": "DRUG" }, { "name": "Current Treatment or no treatment", "type": "DRUG" }, { "name": "Salmeterol 21mcg for 3 Months", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2014-04-09", "completion_date": "2017-05-17", "has_results": true, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024204" }, { "nct_id": "NCT02573233", "title": "Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Dupilumab SAR231893/REGN668", "type": "DRUG" }, { "name": "fluticasone propionate and salmeterol", "type": "DRUG" }, { "name": "budesonide and formoterol", "type": "DRUG" }, { "name": "mometasone furoate and formoterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 42, "start_date": "2016-01-27", "completion_date": "2018-01-03", "has_results": true, "last_update_posted_date": "2022-04-04", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 6, "location_summary": "Tucson, Arizona • Denver, Colorado • Boston, Massachusetts + 3 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02573233" }, { "nct_id": "NCT00118690", "title": "A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bronchospasm", "Activity/Exercise Induced Bronchospasm" ], "interventions": [ { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "4 Years to 17 Years" }, "enrollment_count": 227, "start_date": "2003-12", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2016-09-23", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 51, "location_summary": "Jonesboro, Arkansas • East Artesia, California • Huntington Beach, California + 45 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "East Artesia", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00118690" }, { "nct_id": "NCT00568347", "title": "Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COPD" ], "interventions": [ { "name": "fluticasone 100mcg/ salmeterol 50mcg", "type": "DRUG" }, { "name": "fluticasone 250/salmeterol 50", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "salmeterol and fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arthur F Gelb MD", "sponsor_class": "INDIV", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "20 Years to 85 Years" }, "enrollment_count": 39, "start_date": "2006-01", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2015-03-17", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00568347" }, { "nct_id": "NCT00984659", "title": "Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone propionate/salmeterol combination product", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 366, "start_date": "2009-10-29", "completion_date": "2010-07-01", "has_results": true, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 39, "location_summary": "Jasper, Alabama • Mobile, Alabama • Los Angeles, California + 35 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00984659" }, { "nct_id": "NCT00102882", "title": "Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "salmeterol xinafoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 547, "start_date": "2004-10", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2017-02-03", "last_synced_at": "2026-10-04T08:19:12.521Z", "location_count": 86, "location_summary": "Mobile, Alabama • Little Rock, Arkansas • Fresno, California + 70 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00102882" } ] }